Clinical outcome in venous coronary artery bypass grafting: A 15-year follow-up study

International Journal of Cardiology

Volumn 58, Issue 2, 1997, Pages 119-126

  Van Brussel, B L ^a   Ernst, J M P G ^b   Ernst, N M ^b   Kelder, H C ^b   Knaepen, P J ^b   Plokker, H W M ^b   Vermeulen, F E E ^b   Voors, A A ^b  

^a Diaconessenhuis   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

coronary artery bypass graft; long term outcome; venous graft

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECURRENCE; SAPHENOUS VEIN; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031042284     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02858-6     Document Type: Article

References (26)

1. Alderman EL, Bourassa MG, Cohen LS. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 1990; 82: 1629-1646.
2. Killip T, Passamani E, Davis K, the CASS Principal Investigators and Their Associates. Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation 1985; 72 (suppl V): V-102-V-109.
3. Takaro T, Hultgren HN, Lipton MJ, Detre KM. Participants in the VA Study Group. The VA Cooperative randomized study of surgery for coronary arterial occlusive disease. II, Subgroup with significant left main lesions. Circulation 1976; 54 (suppl III): III-107-III-117.
4. Kirklin JW, Akins CW, Blackstone EH, Booth DC, Califf RM, Cohen LS et al. Guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee on Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 1991; 17: 543-589.
5. Sergeant P, Lesaffre E, Flameng W, Suy R. Internal mammary artery: methods of use and their effect on survival after coronary bypass surgery. Eur J Cardiothorac Surg 1990; 4: 72-78.
6. Bourassa MG. Fate of venous grafts: the past, the present and the future. J Am Coll Cardiol 1991; 17: 1081-1083.
7. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989; 79 (suppl I): I-24-I-29.
8. van Brussel BL, Plokker HWM, Ernst JMPG, Ernst NM, Knaepen PJ, Koomen EM, et al. Venous coronary artery bypass surgery. A 15-year follow-up study. Circulation 1993; 88: 87-92.
9. van Brussel BL, Plokker HWM, Voors AA, Ernst JMPG, Ernst NM, Knaepen PJ, et al. Multivariate risk factor analysis of clinical outcome 15 years after venous coronary artery bypass graft surgery. Eur Heart J 1995; 16: 1200-1206.
10. van Brussel BL, Plokker HWM, Voors AA, Ernst JMPG, Kelder JC, Knaepen PJ et al. Different clinical outcome in coronary artery bypass with single and sequential vein grafts: a fifteen-year follow-up study. J Thorac Cardiovasc Surg 1996; 112: 69-78.
11. CASS Principal Investigators and Their Associates. National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease, and a registry of consecutive patients undergoing coronary angiography. Circulation 1981; 63 (suppl I): I-1-I-81.
12. Drolette ME. The effect of incomplete follow-up. Biometrics 1975; 31: 135-144.
13. Detre KM, Peduzzi P, Takaro T, Hultgren HN, Murphy ML, Kroncke G. Eleven-year survival in the veterans administration randomized trial of coronary bypass surgery for stable angina. New Engl J Med 1984; 33: 1333-1359.
14. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. New Engl J Med 1988; 319: 332-337.
15. Califf RM, Harrell JE Jr, Lee KL, Rankin JS, Hlatky MA, Mark DB et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. J Am Med Assoc 1989; 261: 2077-2086.
16. Cosgrove DM. Determinants of 10-year survival after primary myocardial revascularization. Ann Surg 1985; 202: 480-490.
17. Cameron A, Kemp HG Jr, Green GE. Bypass surgery with the internal mammary artery graft: 15 year follow-up. Circulation 1986; 74 (suppl III): III-30-III-36.
18. Ulicny Jr KS, Flege Jr JB, Callard GM, Todd JC. Twenty-year follow-up of saphenous vein aortocoronary artery bypass grafting. Ann Thorac Surg 1992; 53: 258-262.
19. Rahimtoola SH, Fessler CL, Grunkemeier GL, Starr A. Survival 15 to 20 years after coronary bypass surgery for angina. J Am Coll Cardiol 1993; 21: 151-157.
20. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW et al. Influence of the internal-mammary-artery graft on 10 year survival and other cardiac events. New Engl J Med 1986; 314: 1-7.
21. Lawrie GM, Morris Jr GC, Earle NAN. Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years. Ann Surg 1991; 213: 377-387.
22. Fuster V, Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease. Circulation 1986; 73: 227-232.
23. Gohlke H, Golhke-Bärwolf C, Stürzenhofecker P, Görnandt L, Ritter B, Reichelt M, et al. Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: a prospective, randomized study. Circulation 1981; 64 (suppl II): II-22-II-27.
24. Brown G, Albers JJ, Fisher LD, Schaeffer SM, Jiin-Tarng Lin, Kaplan C, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. New Engl J Med 1990; 323: 1289-1298.
25. Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH. Beneficial effects of Colestipol-Niacin on coronary atherosclerosis. A 4 year follow-up. J Am Med Assoc 1990; 264: 3013-3017.
26. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. New Engl J Med 1987; 317: 1237-1245.